Experimental mathematical validation of a novel concept of extended 2- butoxyethanol autoprotection

International Journal of Toxicology

Volumn 18, Issue 5, 1999, Pages 307-316

  Sawant, Sharad D ^a   Doucet, Paul G ^b   Slob, Wout ^c   Blaylock, Benny L ^a   Mehendale, Harihara M ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

2 Butoxyethanol; Autoprotection; Erythropoietin; Hemolysis; Red blood cells; Reticulocytes

Indexed keywords

2 BUTOXYETHANOL; ALCOHOL DERIVATIVE; ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HEMOLYSIS; MATHEMATICAL ANALYSIS; NONHUMAN; RAT; RETICULOCYTE COUNT; VALIDATION PROCESS;

ANIMALIA;

EID: 0032729787     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/109158199225224     Document Type: Article

References (11)

1. Digavalli, S. V., and H. M. Mehendale. 1995. 2-Butoxyethanol autoprotection is due to resilience of newly formed erythrocytes to hemolysis. Arch. Toxicol. 69:526-532.
2. Ghanayem, B. I., L. T. Burka, J. M. Sanders, and H. B. Matthews. 1987. Metabolism and disposition of ethylene glycol monobutyl ether in rats. Drug Metab. Dispos. 15:478-484.
3. Ghanayem, B. I., S. M. Ward, P. C. Blair, and H. B. Matthews. 1990. Comparison of the hematologic effects of 2-butoxyethanol using two types of hematology analyzers. Toxicol. Appl. Pharmacol. 106:341-345.
4. Glass, G. A., and D. Gershon. 1981. Enzymatic changes in rat erythrocytes with increasing cell and donor age: Loss of superoxide dismutase activity associated with increases in catalytically defective forms. Biochem. Biophys. Res. Commun. 103:1245-1253.
5. Glass, G. A., and D. Gershon. 1984. Decreased enzymatic protection and increased sensitivity to oxidative damage in erythrocytes as a function of cell and donor aging. Biochem. J. 218:531-537.
6. Goldwasser, E., N. Beru, and D. Smith. Erythropoietin: the primary regulator of red cell formation. In Peptide growth factors and their receptors, ed. M. B. Sporn and A. B. Roberts, 747-770. Berlin: Springer-Verlag.
7. Goodnough, L. T., T. H. Price, and C. A. Parvin. 1995. The endogenous erythropoietin response and the erythropoietic response to blood loss anemia: The effects of age and gender. J. Lab. Clin. Med. 126:57-63.
8. Kellermeyer, R. W., A. R. Tarlov, G. W. Brewer, P. E. Carson, and A. S. Alving. 1962. Hemolytic effect of therapeutic drugs: Clinical considerations of the primaquine-type hemolysis. JAMA 180:388-394.
9. Krasavage, W. 1986. Subchronic oral toxicity of ethylene glycol monobutyl ether in male rats. Fundam. Appl. Toxicol. 6:349-355.
10. Metcalf, D. 1989. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339:27-30.
11. Smith, R. 1984. Review of glycol ether and glycol ether ester solvents used in the coating industry. Environ. Health Perspect. 57:1-4.